Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Lanuti

Showing results (201-210 of 241) with videos related to

Pageof 25
Sort By:
Nature Genetics|February 5, 2025
Quantifying cell divisions along evolutionary lineages in cancerMartin Blohmer, David M Cheek, Wei-Ting Hung, et al.
Seminars in Thoracic and Cardiovascular Surgery|December 11, 2024
The Importance of Pulmonary Nodule Features in the Selection of Treatment for the High-Risk Patient with Stage I Non-Small Cell Lung CancerArjun Pennathur, Michael Lanuti, Robert E Merritt, et al.
Seminars in Thoracic and Cardiovascular Surgery|December 14, 2024
Systematic Review of Sublobar Resection for Treatment of High-Risk Patients with Stage I Non-Small Cell Lung CancerRobert E Merritt, Alessandro Brunelli, Garrett Walsh, et al.
Seminars in Thoracic and Cardiovascular Surgery|December 14, 2024
Systematic Review of Stereotactic Ablative Radiotherapy (SABR)/Stereotactic Body Radiation Therapy (SBRT) for Treatment of High-Risk Patients with Stage I Non-Small Cell Lung CancerAndrea Wolf, Billy W Loo, Raymond H Mak, et al.
Seminars in Thoracic and Cardiovascular Surgery|December 13, 2024
Treatment of High-Risk Patients with Stage I Non-Small Cell Lung CancerArjun Pennathur, Michael Lanuti, Robert E Merritt, et al.
Seminars in Thoracic and Cardiovascular Surgery|December 15, 2024
Systematic Review of the Comparative Studies of Image-Guided Thermal Ablation, Stereotactic Radiosurgery, and Sublobar Resection for Treatment of High-Risk Patients with Stage I Non-Small Cell Lung CancerArjun Pennathur, Michael Lanuti, Robert E Merritt, et al.
Journal of Geriatric Oncology|January 25, 2022
Effects of a perioperative geriatric intervention for older adults with Cancer: A randomized clinical trialRyan D Nipp, Carolyn L Qian, Helen P Knight, et al.
Seminars in Thoracic and Cardiovascular Surgery|December 11, 2024
Systematic Review of Image-Guided Thermal Ablation for Treatment of High-Risk Patients with Stage I Non-Small Cell Lung CancerMichael Lanuti, Robert D Suh, Gerard J Criner, et al.
Seminars in Thoracic and Cardiovascular Surgery|December 11, 2024
Treatment Selection for the High-Risk Patient with Stage I Non-Small Cell Lung Cancer: Sublobar Resection, Stereotactic Ablative Radiotherapy or Image-Guided Thermal Ablation?Arjun Pennathur, Michael Lanuti, Robert E Merritt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2020
Fibrotic Response to Neoadjuvant Therapy Predicts Survival in Pancreatic Cancer and Is Measurable with Collagen-Targeted Molecular MRIDerek J Erstad, Mozhdeh Sojoodi, Martin S Taylor, et al.
Pageof 25

Showing results (201-210 of 241) with videos related to

Sort By:
Pageof 25
Nature Genetics|February 5, 2025
Quantifying cell divisions along evolutionary lineages in cancerMartin Blohmer, David M Cheek, Wei-Ting Hung, et al.
Seminars in Thoracic and Cardiovascular Surgery|December 11, 2024
The Importance of Pulmonary Nodule Features in the Selection of Treatment for the High-Risk Patient with Stage I Non-Small Cell Lung CancerArjun Pennathur, Michael Lanuti, Robert E Merritt, et al.
Seminars in Thoracic and Cardiovascular Surgery|December 14, 2024
Systematic Review of Sublobar Resection for Treatment of High-Risk Patients with Stage I Non-Small Cell Lung CancerRobert E Merritt, Alessandro Brunelli, Garrett Walsh, et al.
Seminars in Thoracic and Cardiovascular Surgery|December 14, 2024
Systematic Review of Stereotactic Ablative Radiotherapy (SABR)/Stereotactic Body Radiation Therapy (SBRT) for Treatment of High-Risk Patients with Stage I Non-Small Cell Lung CancerAndrea Wolf, Billy W Loo, Raymond H Mak, et al.
Seminars in Thoracic and Cardiovascular Surgery|December 13, 2024
Treatment of High-Risk Patients with Stage I Non-Small Cell Lung CancerArjun Pennathur, Michael Lanuti, Robert E Merritt, et al.
Seminars in Thoracic and Cardiovascular Surgery|December 15, 2024
Systematic Review of the Comparative Studies of Image-Guided Thermal Ablation, Stereotactic Radiosurgery, and Sublobar Resection for Treatment of High-Risk Patients with Stage I Non-Small Cell Lung CancerArjun Pennathur, Michael Lanuti, Robert E Merritt, et al.
Journal of Geriatric Oncology|January 25, 2022
Effects of a perioperative geriatric intervention for older adults with Cancer: A randomized clinical trialRyan D Nipp, Carolyn L Qian, Helen P Knight, et al.
Seminars in Thoracic and Cardiovascular Surgery|December 11, 2024
Systematic Review of Image-Guided Thermal Ablation for Treatment of High-Risk Patients with Stage I Non-Small Cell Lung CancerMichael Lanuti, Robert D Suh, Gerard J Criner, et al.
Seminars in Thoracic and Cardiovascular Surgery|December 11, 2024
Treatment Selection for the High-Risk Patient with Stage I Non-Small Cell Lung Cancer: Sublobar Resection, Stereotactic Ablative Radiotherapy or Image-Guided Thermal Ablation?Arjun Pennathur, Michael Lanuti, Robert E Merritt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2020
Fibrotic Response to Neoadjuvant Therapy Predicts Survival in Pancreatic Cancer and Is Measurable with Collagen-Targeted Molecular MRIDerek J Erstad, Mozhdeh Sojoodi, Martin S Taylor, et al.
Pageof 25